×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE ...
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. ("SpayVac")...
1 month ago
BioVaxys snatches up 'bankrupt' IMV's preclinical and clinical assets
Pharmaceutical Technology
BioVaxys will pay $750,000 in upfront payments, along with milestone-based payments and royalties on licensing revenue and product sales.
3 months ago
BioVaxys Acquires Full Portfolio of Former IMV
PharmTech
BioVaxys has acquired the full portfolio of discovery, preclinical, and clinical development-stage assets of the former IMV.
3 months ago
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
Canada Newswire
CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the...
3 weeks ago
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") announces that the Ontario Securities...
2 weeks ago
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the...
1 month ago
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") announces that it intends to...
2 months ago
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order USA - English - USA - English
PR Newswire
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order. BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "...
2 months ago
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
PR Newswire
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance...
2 months ago
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS ...
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has...
3 months ago